Welcome to our dedicated page for Macerich SEC filings (Ticker: MAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Macerich Company SEC filings document the reporting, governance and capital-structure matters of a retail real estate investment trust listed on the New York Stock Exchange under the symbol MAC. Form 8-K reports furnish earnings results and supplemental financial and operating information, including financial highlights, capital information, changes in common and equivalent shares or units, and portfolio-related operating data.
Other filings cover Regulation FD business update presentations, annual meeting proxy materials, board and stockholder voting matters, and material agreements involving the company and its operating partnership, The Macerich Partnership, L.P. The filing record also includes disclosures on revolving credit facilities, direct financial obligations, completed property sales, exhibit filings, and the company’s common stock registration and exchange listing.
The Macerich Company entered into an underwritten forward equity offering tied to 14,000,000 shares of its common stock. Forward sellers borrowed and sold the shares to the underwriters, and Macerich entered into related Forward Sale Agreements with multiple forward purchasers.
The company granted the underwriters a 30-day option for up to an additional 2,100,000 shares through Additional Forward Sale Agreements. The Forward Sale Agreements carry an initial forward price of $23.12325 per share and are expected to be physically settled in cash no later than June 16, 2027, though cash or net share settlement is also permitted.
Macerich plans to contribute the net proceeds from settling the Forward Sale Agreements to The Macerich Partnership, L.P., which intends to use the funds for future acquisitions and general corporate purposes, with temporary investment in short-term, interest-bearing deposits.
The Macerich Company intends to offer 14,000,000 shares of its common stock through forward sale agreements with Goldman Sachs, Deutsche Bank, J.P. Morgan and Morgan Stanley, with an underwriter option for an additional 2,100,000 shares. The offering uses forward purchasers who initially sell borrowed shares; the Company will not initially receive proceeds.
The Company expects to physically settle the forward sale agreements on one or more forward settlement dates, expected no later than approximately 12 months from the prospectus supplement. Assuming full physical settlement at an initial forward sale price of $23.12325 per share, estimated net proceeds to the Company are approximately $323,725,500. The Company granted a limited waiver of its 5.0% ownership charter limit to the forward purchasers for this offering.
The Macerich Company is offering 14,000,000 shares of its common stock pursuant to a preliminary prospectus supplement. The offering will be effected through forward sale agreements with Goldman Sachs & Co. LLC and other forward purchasers; the company will not initially receive proceeds from shares sold by the forward purchasers.
The forward sale agreements are expected to be physically settled no later than approximately 12 months from the prospectus supplement date, though the company may elect cash or net share settlement. The underwriters have an option to purchase up to an additional 2,100,000 shares for 30 days.
The Macerich Company is offering 14,000,000 shares of its common stock pursuant to a preliminary prospectus supplement. The offering will be effected through forward sale agreements with Goldman Sachs & Co. LLC and other forward purchasers; the company will not initially receive proceeds from shares sold by the forward purchasers.
The forward sale agreements are expected to be physically settled no later than approximately 12 months from the prospectus supplement date, though the company may elect cash or net share settlement. The underwriters have an option to purchase up to an additional 2,100,000 shares for 30 days.
The Macerich Company reported the results of its annual meeting of stockholders held on June 1, 2026. Stockholders elected eight directors to serve until the next annual meeting, with each nominee receiving over 214 million votes in favor.
Stockholders approved the compensation of the company’s named executive officers, with 211,705,512 votes for, 17,257,788 against and 104,018 abstentions, and 11,123,711 broker non-votes. They also ratified the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 237,981,568 votes for, 2,023,584 against and 185,877 abstentions.
HERNANDEZ ENRIQUE JR reported acquisition or exercise transactions in this Form 4 filing.
MACERICH CO director Enrique Hernandez Jr reported a compensation-related stock award. He received 6,720 shares of Common Stock as a grant of restricted stock units at a price of $0.0000 per share under The Macerich Company 2003 Equity Incentive Plan.
The award is non-cash compensation and the restricted stock units vest one year after the award date. The filing notes 1,818 previously unreported restricted stock units credited as dividend equivalents under the plan’s deferral feature. Following the grant, Hernandez directly holds 71,444 shares and indirectly holds 18,416 shares through a living trust.
Stephen Andrea M reported acquisition or exercise transactions in this Form 4 filing.
Macerich Company director Andrea M. Stephen received a non-cash equity award of 6,720 shares of Common Stock in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan. These restricted stock units vest one year after the award date.
After this grant and the inclusion of 3,413 previously unreported restricted stock units credited as dividend equivalents under the plan’s deferral feature, Stephen’s direct holdings total 104,921 shares of Common Stock.
LAING DIANA reported acquisition or exercise transactions in this Form 4 filing.
Macerich director Diana Laing received a non-cash grant of 6,720 restricted stock units under The Macerich Company 2003 Equity Incentive Plan. These units vest one year after the award date. Following the grant and including 625 dividend-equivalent units, she holds 163,291 common shares/units directly.
Lowenthal Marianne reported acquisition or exercise transactions in this Form 4 filing.
Macerich Company director Marianne Lowenthal received a grant of 6,720 shares of Common Stock as non-cash compensation. The award was in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan and carries a zero dollar grant price. The restricted stock units vest one year after the award date of 2026-06-01. Following this grant, Lowenthal directly holds 43,596 shares of Macerich common stock.
Murphy Devin Ignatius reported acquisition or exercise transactions in this Form 4 filing.
MACERICH CO director Devin Ignatius Murphy reported a stock-based compensation grant rather than a market purchase. He received 6,720 shares of common stock in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan, at no cash cost, which vest one year after the award date. Following this grant, he holds 24,621 shares of common stock directly, including 414 previously unreported restricted stock units credited as dividend equivalents under the plan’s deferral feature.
Hirsch Daniel J. reported acquisition or exercise transactions in this Form 4 filing.
MACERICH CO director Daniel J. Hirsch received a non-cash award of 6,720 restricted stock units of Common Stock under The Macerich Company 2003 Equity Incentive Plan. These units vest one year after the award date. Following the award, he directly holds 91,898 shares and indirectly holds 4,732 shares through a family trust.